CELG Trademark

Trademark Overview

On Thursday, April 15, 2004, a trademark application was filed for CELG with the United States Patent and Trademark Office. The USPTO has given the CELG trademark a serial number of 78402497. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 22, 2007. This trademark is owned by Celgene Corporation. The CELG trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system
celg

General Information

Serial Number78402497
Word MarkCELG
Filing DateThursday, April 15, 2004
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 22, 2007
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 25, 2005

Trademark Statements

Goods and Servicespharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system
Pseudo MarkCELGENE

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, April 23, 2004
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCelgene Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCelgene Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWarren, NJ 07059

Trademark Events

Event DateEvent Description
Tuesday, December 18, 2007ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Tuesday, December 18, 2007ABANDONMENT - NO USE STATEMENT FILED
Saturday, June 9, 2007EXTENSION 4 GRANTED
Friday, March 2, 2007EXTENSION 4 FILED
Friday, March 2, 2007TEAS EXTENSION RECEIVED
Friday, September 29, 2006EXTENSION 3 GRANTED
Friday, September 8, 2006EXTENSION 3 FILED
Friday, September 8, 2006TEAS EXTENSION RECEIVED
Saturday, March 4, 2006EXTENSION 2 GRANTED
Friday, February 17, 2006EXTENSION 2 FILED
Friday, February 17, 2006TEAS EXTENSION RECEIVED
Monday, September 12, 2005EXTENSION 1 GRANTED
Monday, September 12, 2005EXTENSION 1 FILED
Monday, September 12, 2005TEAS EXTENSION RECEIVED
Thursday, June 16, 2005TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, April 19, 2005NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 25, 2005PUBLISHED FOR OPPOSITION
Wednesday, January 5, 2005NOTICE OF PUBLICATION
Monday, November 22, 2004LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, November 19, 2004ASSIGNED TO LIE
Thursday, November 18, 2004APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 17, 2004TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 12, 2004CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 12, 2004TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, November 10, 2004NON-FINAL ACTION E-MAILED
Wednesday, November 10, 2004NON-FINAL ACTION WRITTEN
Monday, November 8, 2004ASSIGNED TO EXAMINER
Friday, April 23, 2004NEW APPLICATION ENTERED IN TRAM

Related Keywords

celg pharmaceutical preparations immune system modulate inhibitory namely cytokine drugs